+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cytarabine"

From
From
From
Acute myeloid leukaemia - Pipeline Insight, 2024 - Product Thumbnail Image

Acute myeloid leukaemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 230 Pages
  • Global
From
Acute lymphocytic leukemia (ALL) - Pipeline Insight, 2024 - Product Thumbnail Image

Acute lymphocytic leukemia (ALL) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 200 Pages
  • Global
From
T-cell Acute Lymphoblastic Leukemia - Pipeline Insight, 2024 - Product Thumbnail Image

T-cell Acute Lymphoblastic Leukemia - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 50 Pages
  • Global
From
From
From
Investigation Report on China's Pegaspargase Market, 2019-2023 - Product Thumbnail Image

Investigation Report on China's Pegaspargase Market, 2019-2023

  • Report
  • September 2019
  • 30 Pages
  • China
From
From
Disease Analysis: Acute Myeloid Leukemia (AML) - Product Thumbnail Image

Disease Analysis: Acute Myeloid Leukemia (AML)

  • Report
  • April 2021
  • 120 Pages
  • Global
From
From
From
From
Loading Indicator

Cytarabine is a chemotherapy drug used to treat acute myeloid leukemia (AML) and other types of leukemia. It is a nucleoside analog, which means it works by interfering with the growth of cancer cells. Cytarabine is usually given intravenously or as an injection into the spinal fluid. It is often used in combination with other drugs to treat AML. Cytarabine is also used to treat other types of cancer, such as lymphoma and multiple myeloma. Cytarabine is a widely used drug in the treatment of leukemia, and is available in both generic and branded forms. It is typically prescribed in combination with other drugs, such as daunorubicin and idarubicin. The drug is available in both oral and injectable forms, and is often used in combination with other drugs to treat AML. The cytarabine market is highly competitive, with many companies offering generic and branded versions of the drug. Some of the major players in the market include Pfizer, Novartis, Merck, Bristol-Myers Squibb, and Teva Pharmaceuticals. Show Less Read more